Small molecules restore mutant mitochondrial DNA polymerase activity
Mammalian mitochondrial DNA (mtDNA) is replicated by DNA polymerase γ (POLγ), a heterotrimeric complex consisting of a catalytic POLγA subunit and two accessory POLγB subunits<sup>1</sup>. More than 300 mutations in POLG, the gene encoding the catalytic subunit, have been linked to severe, progressive conditions with high rates of morbidity and mortality, for which no treatment exists<sup>2</sup>. Here we report on the discovery and characterization of PZL-A, a first-in-class small-molecule activator of mtDNA synthesis that is capable of restoring function to the most common mutant variants of POLγ. PZL-A binds to an allosteric site at the interface between the catalytic POLγA subunit and the proximal POLγB subunit, a region that is unaffected by nearly all disease-causing mutations. The compound restores wild-type-like activity to mutant forms of POLγ in vitro and activates mtDNA synthesis in cells from paediatric patients with lethal POLG disease, thereby enhancing biogenesis of the oxidative phosphorylation machinery and cellular respiration. Our work demonstrates that a small molecule can restore function to mutant DNA polymerases, offering a promising avenue for treating POLG disorders and other severe conditions linked to depletion of mtDNA.
Authors
- Anja V. Gruszczyk (ORCID: https://orcid.org/0000-0003-3060-4107)
- Xie Xie (ORCID: https://orcid.org/0000-0001-9483-7503)
- Andrew M. Griffin
- Claes M. Gustafsson (ORCID: https://orcid.org/0000-0003-3531-8468)
- Simon Ekström (ORCID: https://orcid.org/0000-0002-7694-285X)
- Louise Jenninger
- Thomas A. Keating
- Cindy Phan (ORCID: https://orcid.org/0000-0002-9770-2353)
- Viktor Posse (ORCID: https://orcid.org/0000-0003-4936-4967)
- Barbara Küppers-Munther (ORCID: https://orcid.org/0000-0003-4217-9355)
- Javier Miralles Fusté (ORCID: https://orcid.org/0000-0001-8818-9650)
- Nils‐Göran Larsson (ORCID: https://orcid.org/0000-0001-5100-996X)
- Laleh S. Arabanian (ORCID: https://orcid.org/0000-0003-1126-256X)
- Paul S. Charifson
- S. Jordan Kerns
- Bertil Macao (ORCID: https://orcid.org/0000-0001-6511-6125)
- Sebastian Valenzuela (ORCID: https://orcid.org/0000-0001-5153-8431)
- Jeremy Green (ORCID: https://orcid.org/0000-0003-4544-6412)
- Simon Giroux (ORCID: https://orcid.org/0000-0003-1499-2576)
- Seoeun Lee (ORCID: https://orcid.org/0000-0002-0227-3649)
- Yonghong Shi (ORCID: https://orcid.org/0000-0003-2266-7589)
- Maria Falkenberg (ORCID: https://orcid.org/0000-0001-8713-173X)
- Gabriel Martinez Botella
- Xuefeng Zhu (ORCID: https://orcid.org/0000-0002-4759-4446)
- Juli E. Jones (ORCID: https://orcid.org/0000-0002-3870-1705)
- Karin Johansson
- Carlos Pardo-Hernández
- Günther Kern
- Emily Hoberg
- Mattias Stamgren
- Carol Geukens
Institutions
- Karolinska Institutet (SE)
- Profu (Sweden) (SE)
- APT Therapeutics (United States) (US)
- University of Gothenburg (SE)
Publication Details
- Journal
- Nature
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1038/s41586-025-08856-9
- Citations
- 10
- Primary Topic
- Mitochondrial Function and Pathology
- Type
- article
- Field-Weighted Citation Impact
- 8.06